Role of C-reactive protein in the assessment of cardiovascular risk

Am J Cardiol. 2003 Jan 15;91(2):200-2. doi: 10.1016/s0002-9149(02)03110-7.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antioxidants / therapeutic use
  • C-Reactive Protein / metabolism*
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / prevention & control*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Male
  • Obesity / blood
  • Risk Factors
  • Weight Loss
  • alpha-Tocopherol / therapeutic use

Substances

  • Antioxidants
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • C-Reactive Protein
  • alpha-Tocopherol